Seitaro Mutoh

3.2k total citations
117 papers, 2.7k citations indexed

About

Seitaro Mutoh is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Seitaro Mutoh has authored 117 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 22 papers in Physiology and 20 papers in Surgery. Recurrent topics in Seitaro Mutoh's work include Signaling Pathways in Disease (16 papers), Histone Deacetylase Inhibitors Research (13 papers) and Peroxisome Proliferator-Activated Receptors (10 papers). Seitaro Mutoh is often cited by papers focused on Signaling Pathways in Disease (16 papers), Histone Deacetylase Inhibitors Research (13 papers) and Peroxisome Proliferator-Activated Receptors (10 papers). Seitaro Mutoh collaborates with scholars based in Japan, United States and New Zealand. Seitaro Mutoh's co-authors include Y. Ohkubo, Nobuya Matsuoka, Isamu Yamaguchi, Masahiko Matsuo, Atsushi Nomoto, Tatsuya Sasakawa, Yuka Sasakawa, Toshitaka Manda, Jiro Hirosumi and Takahisa Noto and has published in prestigious journals such as Cancer Research, Brain Research and FEBS Letters.

In The Last Decade

Seitaro Mutoh

116 papers receiving 2.6k citations

Peers

Countries citing papers authored by Seitaro Mutoh

Since Specialization

Citations

This map shows the geographic impact of Seitaro Mutoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seitaro Mutoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seitaro Mutoh more than expected).

Fields of papers citing papers by Seitaro Mutoh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seitaro Mutoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seitaro Mutoh. The network helps show where Seitaro Mutoh may publish in the future.

Co-authorship network of co-authors of Seitaro Mutoh

This figure shows the co-authorship network connecting the top 25 collaborators of Seitaro Mutoh. A scholar is included among the top collaborators of Seitaro Mutoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seitaro Mutoh. Seitaro Mutoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a System of Strategic Research Administration at Kyoto University 2014 ·Tadashi Sugihara, (unknown), Seitaro Mutoh	0
2	Anti-Inflammatory Profile of AS2444697, A Novel Interleukin-1 Receptor-Associated Kinase-4 Inhibitor 2011 ·Arthritis & Rheumatism ·Hiroyuki Usuda, S Nagashima, Ito T, Toru Kontani, Yusuke Shimizu, Seitaro Mutoh, Jun Watanabe, (unknown), (unknown), Jirô Imanishi, Takeshi Ishikawa, (unknown), Hidekazu Mizuhara, (unknown), (unknown)	2
3	Thirteen-month inhibition of aldose reductase by zenarestat prevents morphological abnormalities in the dorsal root ganglia of streptozotocin-induced diabetic rats 2008 ·Brain Research ·(unknown), (unknown), Nobuya Matsuoka, Shoji Takakura, Seitaro Mutoh, Mikiko Kamijo	17
4	FK1706, a novel non-immunosuppressive immunophilin ligand, modifies the course of painful diabetic neuropathy 2008 ·Neuropharmacology ·Shunji Yamazaki, Takayuki Yamaji, Nobuhito Murai, Hiroko Yamamoto, Raymond D. Price, Nobuya Matsuoka, Seitaro Mutoh	8
5	Mechanism of HDAC inhibitor FR235222-mediated IL-2 transcriptional repression in Jurkat cells 2007 ·International Immunopharmacology ·Hideaki Matsuoka, (unknown), Hiroaki Mori, Ichiro Aramori, Seitaro Mutoh	18
6	Inhibitory Effect of Zacopride on Cisplatin-Induced Delayed Emesis in Ferrets 2006 ·Journal of Pharmacological Sciences ·(unknown), (unknown), Shigeo Matsui, (unknown), Masahiko Matsuo, Seitaro Mutoh	10
7	Tacrolimus (FK506) attenuates biphasic cytochrome c release and Bad phosphorylation following transient cerebral ischemia in mice 2006 ·Neuroscience ·(unknown), Yasuhisa Furuichi, N. Matsuoka, Seitaro Mutoh, Takehiko Yanagihara	19
8	Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP‐ribose) polymerase‐1/2 inhibitors 2005 ·FEBS Letters ·Akinori Iwashita, Kouji Hattori, Hirofumi Yamamoto, Junya Ishida, Yoshiyuki Kido, Kazunori Kamijo, Kenji Murano, Hiroshi Miyake, Takayoshi Kinoshita, Masaichi Warizaya, Mitsuru Ohkubo, Nobuya Matsuoka, Seitaro Mutoh	65
9	Characterization of the anti‐platelet actions of FK419, a novel non‐peptide antagonist of platelet GPIIb/IIIa 2004 ·Drug Development Research ·Kayoko Mihara, Toshiaki Aoki, Akira Moriguchi, Hiroko Yamamoto, Masashi Maeda, (unknown), Toshio Yamanaka, Mitsuru Ohkubo, Nobuya Matsuoka, Jiro Seki, Seitaro Mutoh	23
10	The cytotoxic effects of FK228, histone deacetylase inhibitor, in combination with other anticancer agents. 2004 ·Cancer Research ·Yoshinori Naoe, Takeshi Inoue, Masahiko Matsuo, Seitaro Mutoh, Yasuhiko Kano	1
11	A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Akinori Iwashita, Kayoko Mihara, (unknown), (unknown), Junya Ishida, Hirofumi Yamamoto, Kouji Hattori, Nobuya Matsuoka, Seitaro Mutoh	32
12	A gastrointestinal lipase inhibitor reduces progression of atherosclerosis in mice fed a western-type diet 2004 ·European Journal of Pharmacology ·Koji Ueshima, (unknown), (unknown), Shoji Takakura, Masahiko Matsuo, Seitaro Mutoh	13
13	A Novel and Potent Poly(ADP-Ribose) Polymerase-1 Inhibitor, FR247304 (5-Chloro-2-[3-(4-phenyl-3,6-dihydro-1(2 H)-pyridinyl)propyl]-4(3 H)-quinazolinone), Attenuates Neuronal Damage in in Vitro and in Vivo Models of Cerebral Ischemia 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Akinori Iwashita, (unknown), (unknown), (unknown), Kazunori Kamijo, Junya Ishida, Hirofumi Yamamoto, Kouji Hattori, Nobuya Matsuoka, Seitaro Mutoh	66
14	Effect of systemic FR140423, a new analgesic compound, in a rat model of postoperative pain: contribution of delta-opioid receptors 2003 ·Neuroscience Letters ·Takehiro Ochi, Y. Ohkubo, Seitaro Mutoh	4
15	Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig 2003 ·European Journal of Pharmacology ·Yasuko Kato, Yasuhiro Kita, (unknown), Mie Nishio, Kayoko Mihara, Kiyotaka Ito, Toshio Yamanaka, Jiro Seki, Susumu Miyata, Seitaro Mutoh	75
16	Choleretic Actions of Insulin-Like Growth Factor-I, Prednisolone, and Ursodeoxycholic Acid in Rats 2003 ·Digestive Diseases and Sciences ·Miyuki Mabuchi, Ikuo Kawamura, (unknown), (unknown), Shoji Takakura, Jiro Hirosumi, Seitaro Mutoh	2
17	Resiniferatoxin antagonizes cisplatin-induced emesis in dogs and ferrets 2002 ·European Journal of Pharmacology ·(unknown), (unknown), (unknown), Yasue Maeda, Masahiko Matsuo, Toshitaka Manda, Seitaro Mutoh	22
18	Possible Involvement of Corticosterone in Bone Loss of Genetically Diabetic db/db Mice 2000 ·Hormone and Metabolic Research ·Nobuaki Takeshita, (unknown), Seitaro Mutoh	9
19	Plasma Cholesterol Reducing Effect of FR129169, a Novel Acyl-CoA:Cholesterol Acyltransferase Inhibitor, in the Rat 1996 ·The Japanese Journal of Pharmacology ·(unknown), Hiroyuki Hagihara, (unknown), (unknown), Seitaro Mutoh, (unknown), Yoshitada Notsu, MASAKUNI OKUHARA	13
20	Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipine 1988 ·Atherosclerosis ·Atsushi Nomoto, Seitaro Mutoh, Hiroyuki Hagihara, Isamu Yamaguchi	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact